CODICE CONCORSO 2019POR023 PROCEDURA VALUTATIVA DI CHIAMATA PER LA COPERTURA DI N.1 POSTO DI PROFESSORE UNIVERSITARIO DI RUOLO D
program outcome in follicular lymphomas treated with a rituximab-intensive Persistence of minimal residual disease in bone marro
![PDF) The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up | Luciano PDF) The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up | Luciano](https://0.academia-photos.com/attachment_thumbnails/38015571/mini_magick20190226-12159-1pf5l0u.png?1551245575)
PDF) The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up | Luciano
![PDF) Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: Consensus of an Italian expert panel | R. Masetti - Academia.edu PDF) Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: Consensus of an Italian expert panel | R. Masetti - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/50741349/mini_magick20190127-13551-1so7by0.png?1548645327)